Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

Mutations in the FOXN1 gene cause severe immune issues but don't affect hair and nails.

Cannabidivarin (CBDV) helps new brain cells grow and develop in a specific brain area through a certain receptor.

Plasmatherapy improves immune status in vitiligo patients, especially those with segmental vitiligo.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Immunocompromised patients can develop skin and hair issues due to a virus.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

Alopecia areata involves specific immune cells, offering potential treatment targets.

The treatment was effective for advanced non-Hodgkin's lymphomas.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Controlling Tslp can improve health in AEC syndrome patients.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Alopecia areata is linked to reduced T cell function and auto-immunity.

The gene Tfap2b is essential for creating a type of stem cell in zebrafish that can become different pigment cells.

HPV16 oncogenes disrupt the normal activity of hair follicle stem cells.

The FDA approved a new Pfizer drug for hair loss in teens.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Anti-Ku-positive patients often have muscle weakness and autophagy plays a key role in their condition.

Patient-derived stem cell melanocytes could be a promising treatment for vitiligo.

GKLF/KLF4 and Sp1 control Keratin 19 gene activity, influencing cancer-related changes.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

Trichilemmal carcinoma shares genetic changes with other skin cancers, suggesting similar causes and potential treatments.

CD44 variant changes start alopecia areata, but don't maintain it.

p63 is essential for skin cell growth and differentiation by controlling specific gene networks.

mHa2 and mHa3 keratins have different structures and roles in mouse hair and tongue tissues.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Interleukin-1 increases keratin K6 production in skin cells.